Inventor · New York, NY, US

Anne-Laure Flamar

17Patents
11h-index
12Co-inventors
65Inventor score

Filing activity: Jan 31, 2008 → Apr 12, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7786267B2 Multivariable antigens complexed with targeting humanized monoclonal antibody Chemistry; Metallurgy 42 Active
US8518410B2 Fusion protein with HIV antigen Emerging Cross-Sectional Technologies 40 Active
US9102734B2 Fusion proteins comprising antibody and HPV E6 and E7 antigens Emerging Cross-Sectional Technologies 39 Active
US8961991B2 Anti-CD40 targeted fusion proteins Emerging Cross-Sectional Technologies 38 Active
US8449888B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 34 Active
US8057798B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 28 Active
US9416186B2 Antigen presenting cell targeted anti-viral vaccines Emerging Cross-Sectional Technologies 25 Active
US9234040B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US9102730B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US8586052B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US9109011B2 Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Chemistry; Metallurgy 13 Active
US10722572B2 Methods and compositions for treating and preventing HIV Chemistry; Metallurgy 0 Active
US10980869B2 Fusion proteins comprising an anti-CD40 antibody and cancer antigens Emerging Cross-Sectional Technologies 0 Active
US10988544B2 Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides Emerging Cross-Sectional Technologies 0 Active
US11219683B2 Methods and compositions for treating and preventing HIV Chemistry; Metallurgy 0 Active
US10610585B2 Methods and compositions for treating and preventing HIV Chemistry; Metallurgy 0 Active
US11806390B2 Fusion proteins comprising an anti-CD40 antibody and cancer antigens Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.